Last update 23 Jan 2025

Eslinko (Suzhou) Biomedical Co., Ltd.

Private Company|
2021|
Jiangsu Sheng, China

Overview

Tags

Nervous System Diseases
Congenital Disorders
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
UGCG(Ceramide glucosyltransferase)1

Related

1
Drugs associated with Eslinko (Suzhou) Biomedical Co., Ltd.
AL-01211
Target
UGCG
Mechanism
UGCG inhibitors
Active Org.
AceLink Therapeutics, Inc.AceLink Therapeutics, Inc. [+1]
Originator Org.
AceLink Therapeutics, Inc.AceLink Therapeutics, Inc.
Active Indication
Fabry Disease [+3]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Eslinko (Suzhou) Biomedical Co., Ltd.
CTR20231170
/ RecruitingPhase 2
一项在既往未接受过任何法布雷病相关治疗的经典型法布雷病男性受试者 中评估AL01211 的安全性、药效学、药代动力学和有效性探索的II 期、 开放性研究
[Translation] A Phase II, open-label study evaluating the safety, pharmacodynamics, pharmacokinetics, and efficacy of AL01211 in male subjects with classic Fabry disease who have not received any prior Fabry disease-related treatment
CTR20221202
/ CompletedPhase 1
一项在健康志愿者中评估AL01211 口服给药的安全性、耐受性、药代动力学和药效学的 I 期、随机、双盲、安慰剂对照、单次和多次给药剂量递增研究
[Translation] A Phase I, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral AL01211 in healthy volunteers
100 Clinical Results associated with Eslinko (Suzhou) Biomedical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Eslinko (Suzhou) Biomedical Co., Ltd.
Login to view more data
100 Deals associated with Eslinko (Suzhou) Biomedical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Eslinko (Suzhou) Biomedical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
AL-01211
 ( UGCG )		Fabry Disease
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free